Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Isomorphic adds Merck to drug discovery roster after $5B raise
Days after raising $5 billion, Isomorphic has added Merck & Co. to a list of partners that now includes three of the top four drugmakers by revenue.
Nick Paul Taylor
Nov 19, 2026 8:47am
Pfizer buys 3 in vivo CAR-Ts in $2.6B deal with China’s Starna
Nov 18, 2026 8:30am
Big Pharmas tell Fierce's London event about their ideal biotech
Nov 18, 2026 5:18am
Vertex re-ups Genomics deal in long-running discovery pact
Nov 18, 2026 5:01am
Lilly signs $5.9B deal with Stipple to unlock oncology targets
Nov 17, 2026 5:30am
Biogen inks $411M pact for TrimTech’s protein degrader skills
Nov 16, 2026 10:00am